Glenn Barney - Proteome Sciences Insider

Proteome Sciences plc -- UK Stock  

GBp 3.16  0.005  0.16%

VP of Bus. Devel. - USA

Mr. Glenn Barney is Vice President Business Development, USA of Proteome Sciences PLC. Glenn brings over 25 years of sales and business development experience with global life sciences companies, with strong biomarker focus. He was formerly VP Business Development at NextGen Sciences Inc. and held senior positions at Decision Biomarkers and Parkin Elmer Inc
  VP Since 2011      
44 19 3286 5065  http://www.proteomics.com
Barney holds a BA in Biology from Boston University..

Management Efficiency

The company has return on total asset (ROA) of (20.17) % which means that it has lost $20.17 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (16.4) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 8.93 M in total debt. Proteome Sciences plc has Current Ratio of 0.38 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Entity Summary

Proteome Sciences plc, a life sciences company, engages in the research and development of biomarkers. Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Cobham, KT EP and employs 35 people.

Did you try this?

Run Efficient Frontier Now
   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
Hide  View All  Next  Launch Efficient Frontier
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Proteome Sciences plc to your portfolio

Top Management

Proteome Sciences plc Leadership Team
William Dawson, Director
Roger McDowell, Director
Christopher Pearce, Director
Ian Pike, Director, Ph.D
Richard Dennis, Executive
Malcolm Ward, Executive
Martin Diggle, Director
Jeremy Haigh, CEO
Josef Schwarz, Executive, MBA
Ursula Ney, Director, Ph.D
Glenn Barney, VP
Gee Chee, Director, Ph.D
Geoffrey Ellis, Director

Stock Performance

Proteome Sciences Performance Indicators